Orient Pharma Co., Ltd. (TPEX:4166)

Orient Pharma Revenue

Orient Pharma had revenue of 427.08M TWD in the quarter ending June 30, 2026, with 31.19% growth. This brings the company's total for the last twelve months to 1.52B, up 20.12% year-over-year. In the year 2025, Orient Pharma had annual revenue of 1.40B with 14.52% growth. That makes Orient Pharma the 28,435th largest company in the world by revenue and 1,346th in Taiwan.

• Revenue (ttm): 1.52B
• Revenue Growth: +20.12%
• P/S Ratio: 3.82
• Revenue / Employee: 8.76M
• Employees: 173
• Market Cap: 5.80B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Taiwan Business Division 1.07B 76.5%
• Overseas Business Division 329.26M 23.5%

By Geography

Chart

• Taiwan 1.07B 76.5%
• United States 232.29M 16.6%
• Philippines 48.68M 3.5%
• Others 48.09M 3.4%
• China 193.00K 0.0%

Fiscal year ended Dec 31, 2025 See the full Orient Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.40B	177.56M	14.52%
Dec 31, 2024	1.22B	332.90M	37.41%
Dec 31, 2023	889.91M	378.05M	73.86%
Dec 31, 2022	511.86M	48.52M	10.47%
Dec 31, 2021	463.34M	51.33M	12.46%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error